secwatch / observer
8-K filed February 5, 2026, 6:59 PM ET ticker SRTA CIK 0001779128
debt confidence high sentiment positive materiality 0.65

Strata Critical Medical secures $30M ABL credit facility from JPMorgan for acquisitions

Strata Critical Medical, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Strata Critical Medical, Inc. entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, the other Loan Parties thereto, and the Lenders thereto valued at up to $30.0 million (effective 2026-01-30).

Action
entry
Agreement
credit facility
Counterparty
JPMorgan Chase Bank, N.A., as administrative agent, the other Loan Parties thereto, and the Lenders thereto
Value
up to $30.0 million
Effective
2026-01-30
Exact text from the filing
On January 30, 2026 (the “Closing Date”), Strata Critical Medical, Inc. (the “Company”), Strata Critical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Critical”), Trinity Air Medical, LLC, an Arizona limited liability company and wholly owned subsidiary of Critical (“Trinity Air”), Keystone Perfusion Services, LLC, a Pennsylvania limited liability company and wholly owned subsidiary of Critical (“Keystone”; together with Trinity Air and any other person that becomes party thereto as a Borrower, collectively, the “Borrowers”), entered into a Credit Agreement (the “Credit Agreement”) among the Borrowers, the Company and Critical, JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), the other Loan Parties thereto, and the Lenders thereto.
View on SEC.gov

329 material agreements filed in the last 30 days. Browse all material agreements →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-26-010689
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.